Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-18-009302)

Filing Details

Accession Number:: 0001179110-18-009302
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-03 14:32:38
Reporting Period:: 2018-06-29

Accepted Time:: 2018-07-03 14:32:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1280600	Acceleron Pharma Inc	XLRN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1214938	F Kevin Mclaughlin	128 Sidney Street Cambridge MA 02139	Svp, Cfo And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-29	25,000	$24.11	68,939	No	4	M	Direct
Common Stock	Disposition	2018-06-29	12,500	$47.00	56,439	No	4	S	Direct
Common Stock	Disposition	2018-06-29	12,500	$49.00	43,939	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to Purchase Common Stock	Disposition	2018-06-29	25,000	$0.00	25,000	$24.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,000		2023-12-05	No	4	M	Direct

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.